Search results for "Cystic"

showing 10 items of 461 documents

Right atrium compression by a renal cyst: a tomographic diagnosis.

2011

Malemedicine.medical_specialtyWhole body imagingmedicinePolycystic kidney diseaseHumansCystWhole Body ImagingHeart AtriaLungPolycystic Kidney DiseasesLungbusiness.industryRight atrium compression renal cystGeneral MedicineMiddle Agedmedicine.diseaseCompression (physics)Settore MED/11 - Malattie Dell'Apparato CardiovascolareTomography x ray computedmedicine.anatomical_structureLiverRight atriumRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedHeart atriumJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

The spectrum of androgen excess disorders.

2006

A better understanding of the different phenotypes and of their endocrine and metabolic characteristics permits investigators to distinguish three main androgen excess disorders: classic polycystic ovary syndrome (PCOS), mild ovulatory PCOS, and idiopathic hyperandrogenism. These androgenic phenotypes differ more for the severity of the endocrine and metabolic alteration than for the etiopathogenetic mechanisms. The appearance of a particular androgenic phenotype is determined by a sum of genetic and environmental factors, but mostly by body weight.

Malemedicine.medical_specialtymedicine.drug_classBiologyAndrogen ExcessDiagnosis DifferentialInsulin resistancePolycystic ovary syndrome hyperandrogenism androgen excess insulin resistance idiopathic hirsutismInternal medicinemedicineEndocrine systemHumanshirsutismHyperandrogenismObstetrics and Gynecologymedicine.diseaseAndrogenPhenotypePolycystic ovaryEndocrinologyReproductive MedicinePractice Guidelines as TopicAndrogensFemaleHyperandrogenismPolycystic Ovary SyndromeFertility and sterility
researchProduct

Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease

2018

BackgroundThe indication to bilateral nephrectomy in patients with autosomal dominant polycystic kidney scheduled for kidney transplantation is controversial. Indeed, the progressive enlargement of cysts may increase the risk of complications and the need for nephrectomy. However, very few studies investigated the change in kidney volume after kidney transplantation.Material and methodsIn this prospective cohort study, the change in native kidney volume in polycystic patients was evaluated with magnetic resonance imaging. Forty patients were included in the study. Kidney diameters and total kidney volume were evaluated with magnetic resonance imaging in patients who underwent simultaneous n…

Malemedicine.medical_treatment030232 urology & nephrology030204 cardiovascular system & hematologyKidneyPathology and Laboratory MedicineNephrectomyVascular MedicineDiagnostic Radiology0302 clinical medicineChronic Kidney DiseaseMedicine and Health SciencesRenal TransplantationPolycystic kidney diseaseMedicineProspective StudiesTomographyKidney transplantationPolycystic Kidney DiseasesKidneyMultidisciplinaryRadiology and ImagingQROrgan SizeMiddle AgedMagnetic Resonance ImagingNephrectomyTreatment Outcomemedicine.anatomical_structureNephrologyMedicineFemaleAnatomymedicine.symptomResearch Articlemedicine.medical_specialtyImaging TechniquesScienceUrologySurgical and Invasive Medical ProceduresHemorrhageNeuroimagingKidney VolumeResearch and Analysis MethodsAsymptomaticUrinary System Procedures03 medical and health sciencesSigns and SymptomsDiagnostic MedicineMedical DialysisHumansTransplantationSurgical Excisionurogenital systembusiness.industryBiology and Life SciencesKidneysRenal SystemOrgan Transplantationmedicine.diseaseKidney TransplantationComputed Axial TomographyTransplantationbusinessFollow-Up StudiesNeuroscienceBilateral NephrectomyPLOS ONE
researchProduct

Mucus and Cell-Penetrating Nanoparticles Embedded in Nano-into-Micro Formulations for Pulmonary Delivery of Ivacaftor in Patients with Cystic Fibrosis

2017

Here, mucus-penetrating nanoparticles (NPs) for pulmonary administration of ivacaftor in patients with cystic fibrosis (CF) were produced with the dual aim of enhancing ivacaftor delivery to the airway epithelial cells, by rapid diffusion through the mucus barrier, and at the same time, promoting ivacaftor lung cellular uptake. Pegylated and Tat-decorated fluorescent nanoparticles (FNPs) were produced by nanoprecipitation, starting from two synthetic copolymers, and showed nanometric sizes (∼70 nm), a slightly negative ζ potential, and high cytocompatibility toward human bronchial epithelium cells. After having showed the significant presence of poly(ethylene glycol) chains and Tat protein …

Materials scienceCystic FibrosisNanoparticle02 engineering and technologyQuinolones010402 general chemistryAminophenols01 natural sciencesCystic fibrosisIvacaftorchemistry.chemical_compoundmedicineHumansGeneral Materials ScienceMicroparticleDrug CarriersLungαβ-poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)ivacaftor (VX-770)mucus-penetrating nanoparticlerespiratory system021001 nanoscience & nanotechnologymedicine.diseaseMucus0104 chemical sciencesMucusnano-into-micro strategymedicine.anatomical_structurechemistrycell penetrating peptideCell-penetrating peptideBiophysicsNanoparticlescystic fibrosis artificial mucus (CF-AM)0210 nano-technologyEthylene glycolmedicine.drug
researchProduct

Neurocysticercosis with a single brain lesion in Germany: a case report

2009

Neurocysticercosis is rare in Western Europe and a high degree of physician awareness is necessary for diagnosis. We describe a case of Neurocysticercosis with a single brain lesion acquired in Germany in which only surgical removal and subsequent histological examination allowed diagnosis whereas diagnostic investigation yielded no pathological findings.

Medicine(all)Pathologymedicine.medical_specialtybusiness.industryNeurocysticercosisCysticercosisGeneral Medicinemedicine.diseaseAlbendazoleSurgical removalWestern europeResearch articlemedicineBrain lesionsbusinessPathologicalmedicine.drugHistological examinationCases Journal
researchProduct

WITHDRAWN: Taeniasis vs cysticercosis infection routes

2016

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Medicine(all)medicine.medical_specialtyPediatricsbusiness.industry030231 tropical medicineCysticercosisGeneral Medicinemedicine.diseaseGeneralLiterature_MISCELLANEOUSSurgery03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMedicineTaeniasisbusinessAsian Pacific Journal of Tropical Medicine
researchProduct

Linfangioma cistico mesenterico. Descrizione di un caso e revisione della letteratura.

2006

Objective: The Authors report their experience in diagnosis and treatment of one case of mesenteric cystic lymphangioma; recent international literature review. Experimental Design: Complete clinical report. Diagnostic, clinical and prognostic indication, evaluation of effectiveness of radical surgical treatment and follow-up. Setting: Operative Unit of General and Thoracic Surgery. University "Paolo Giaccone" of Palermo. Intervention: Radical surgical treatment, according to international guide-lines. Results: Complete recovery with "restitutio ad integrum". No relapse were recorded at short follow up. Conclusions: Even when asymptomatic and discovered incidentally, LCM must be treated sur…

Mesenteric CystLymphangiomaLymphangioma Cystic
researchProduct

Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.

2008

ABSTRACT We report the isolation of thymidine-dependent small-colony variants (TD-SCVs) of Staphylococcus aureus from unusual infection sites of patients with chronic soft tissue infection, tympanitis, bronchitis, peritonitis, and septicemia. Furthermore, we provide evidence that the essential growth factor for TD-SCVs, i.e., thymidine, and its metabolite dTMP are present in various human specimens.

Microbiology (medical)AdultMaleStaphylococcus aureusPancreatic diseaseCystic FibrosisPeritonitisPeritonitismedicine.disease_causeCystic fibrosischemistry.chemical_compoundSepsisPulmonary fibrosismedicineHumansBronchitisChildbusiness.industryRespiratory diseaseBacteriologyPneumoniaMiddle AgedStaphylococcal Infectionsmedicine.diseasechemistryStaphylococcus aureusImmunologyBronchitisFemalebusinessThymidineThymidineJournal of clinical microbiology
researchProduct

The specificity of the electroimmunotransfer blot assay for Taenia solium cysticercosis

2007

Microbiology (medical)Blotmedicine.drug_formulation_ingredientInfectious DiseasesTaenia soliummedicineCysticercosisGeneral MedicineBiologymedicine.diseaseVirologyClinical Microbiology and Infection
researchProduct

Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.

2021

Cystic fibrosis (CF) is a genetic disease that causes absence or dysfunction of a protein named transmembrane conductance regulatory protein (CFTR) that works as an anion channel. As a result, the secretions of the organs where CFTR is expressed are very viscous, so their functionality is altered. The main cause of morbidity is due to the involvement of the respiratory system as a result of recurrent respiratory infections by different pathogens. In recent decades, survival has been increasing, rising by around age 50. This is due to the monitoring of patients in multidisciplinary units, early diagnosis with neonatal screening, and advances in treatments. In this chapter, we will approach t…

Microbiology (medical)medicine.drug_classAntibioticsRNA therapyInflammationDiseaseRM1-950ReviewBioinformaticsBiochemistryMicrobiologyCystic fibrosiscystic fibrosis03 medical and health sciences0302 clinical medicineantibioticmedicinePharmacology (medical)030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsRespiratory systemGeneCFTR modulatorRegulation of gene expressiontreatmentbusiness.industrymedicine.diseaseobstructionTransmembrane proteinInfectious Diseases030228 respiratory systeminflammationediting geneTherapeutics. Pharmacologymedicine.symptombusinessgenetic therapyAntibiotics (Basel, Switzerland)
researchProduct